Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faubel is a specialized provider of functional labels and innovative packaging solutions, primarily serving the pharmaceutical and life sciences industries. The company is a market leader in clinical trial labeling, offering complex products such as multi-layer booklet labels and the Faubel-Med Label, which supports electronic clinical trials. Their technology suite includes smart packaging solutions like RFID and E-Paper, designed to enhance supply chain transparency and patient compliance. Founded in 1855 and based in Melsungen, Germany, Faubel provides critical support for global drug development through its specialized manufacturing capabilities. In August 2023, the company was acquired by CCL Industries, integrating its expertise into CCL's global healthcare and specialty labeling business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faubel.